Snipe Medical is redefining lung cancer treatment with its minimally invasive, endobronchial ablation device, utilizing irreversible electroporation (IRE) to achieve precise, non-thermal tumor ablation. Developed as a safer, more effective alternative to traditional therapies, Snipe’s technology empowers interventional pulmonologists to target tumors with unmatched precision, reducing recovery times and enhancing patient outcomes. By introducing this targeted, minimally invasive approach, Snipe Medical is setting a new standard in cancer care, making advanced treatment both more accessible and impactful for patients worldwide.